1-11 of 11
Soo Chin Lee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer

Joline S.J. Lim, Andrea L.A. Wong, Samuel G.W. Ow, Natalie Y.L. Ngoi, Gloria H.J. Chan, Yvonne L.E. Ang, Wan Qin Chong, Siew Eng Lim, Yi Wan Lim, Matilda Lee, Joan R.E. Choo, Hon Lyn Tan, Wei Peng Yong, Ross A. Soo, David S.P. Tan, Cheng Ean Chee, Raghav Sundar, Kritika Yadav, Supriya Jain, Lingzhi Wang, Bee Choo Tai, Boon Cher Goh, Soo-Chin Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (11): 2248–2256.
https://doi.org/10.1158/1078-0432.CCR-21-4179
Published: 01 June 2022
View article titled, Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer
Open the PDF for Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Phase Ib Study of Ribociclib plus Fulvestrant and Ribociclib plus Fulvestrant plus PI3K Inhibitor (Alpelisib or Buparlisib) for HR+ Advanced Breast Cancer

Sara M. Tolaney, Young-Hyuck Im, Emiliano Calvo, Yen-Shen Lu, Erika Hamilton, Andres Forero-Torres, Thomas Bachelot, Michela Maur, Angelica Fasolo, Ralph Tiedt, Lisa Nardi, Uz Stammberger, Ahmed M. Abdelhady, Shiling Ruan, Soo Chin Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (2): 418–428.
https://doi.org/10.1158/1078-0432.CCR-20-0645
Published: 19 January 2021
View article titled, Phase Ib Study of Ribociclib plus Fulvestrant and Ribociclib plus Fulvestrant plus PI3K Inhibitor (Alpelisib or Buparlisib) for HR<sup>+</sup> Advanced Breast Cancer
Open the PDF for Phase Ib Study of Ribociclib plus Fulvestrant and Ribociclib plus Fulvestrant plus PI3K Inhibitor (Alpelisib or Buparlisib) for HR<sup>+</sup> Advanced Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma

Wan Qin Chong, Chwee Ming Lim, Arvind Kumar Sinha, Chee Seng Tan, Gloria Hui Jia Chan, Yiqing Huang, Nesaretnam Barr Kumarakulasinghe, Raghav Sundar, Anand D. Jeyasekharan, Woei Shyang Loh, Joshua K. Tay, Kritika Yadav, Lingzhi Wang, Andrea L. Wong, Li Ren Kong, Ross Andrew Soo, Jieying Amelia Lau, Yu Yang Soon, Robby Miguel Goh, Francis Cho Hao Ho, Siew Meng Chong, Soo Chin Lee, Kwok Seng Loh, Bee Choo Tai, Yaw Chyn Lim, Boon Cher Goh
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (20): 5320–5328.
https://doi.org/10.1158/1078-0432.CCR-20-1727
Published: 15 October 2020
View article titled, Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma
Open the PDF for Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma in another window
Includes: Supplementary data
Journal Articles

Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers

Soo-Chin Lee, Noriko Shimasaki, Joline S.J. Lim, Andrea Wong, Kritika Yadav, Wei Peng Yong, Lip Kun Tan, Liang Piu Koh, Michelle L.M. Poon, Sing Huang Tan, Samuel G.W. Ow, Lavina Bharwani, Yoon Sim Yap, Mabel Z.Q. Foo, Elaine Coustan-Smith, Raghav Sundar, Hon Lyn Tan, Wan Qin Chong, Nesaretnam Barr Kumarakulasinghe, Jedidah L.M. Lieow, Priscillia J.X. Koe, Boon Cher Goh, Dario Campana
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (17): 4494–4502.
https://doi.org/10.1158/1078-0432.CCR-20-0768
Published: 01 September 2020
View article titled, Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers
Open the PDF for Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers in another window
Includes: Supplementary data
Journal Articles

Elevated WBP2 Expression in HER2-positive Breast Cancers Correlates with Sensitivity to Trastuzumab-based Neoadjuvant Therapy: A Retrospective and Multicentric Study

Shin-Ae Kang, Jye Swei Guan, Hock Jin Tan, Tinghine Chu, Aye Aye Thike, Cristina Bernadó, Joaquín Arribas, Chow Yin Wong, Puay Hoon Tan, Mihir Gudi, Thomas Choudary Putti, Joohyuk Sohn, Swee Ho Lim, Soo Chin Lee, Yoon Pin Lim
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (8): 2588–2600.
https://doi.org/10.1158/1078-0432.CCR-18-3228
Published: 15 April 2019
View article titled, Elevated WBP2 Expression in HER2-positive Breast Cancers Correlates with Sensitivity to Trastuzumab-based Neoadjuvant Therapy: A Retrospective and Multicentric Study
Open the PDF for Elevated WBP2 Expression in HER2-positive Breast Cancers Correlates with Sensitivity to Trastuzumab-based Neoadjuvant Therapy: A Retrospective and Multicentric Study in another window
Includes: Supplementary data
Journal Articles

Significant Effect of Polymorphisms in CYP2D6 on Response to Tamoxifen Therapy for Breast Cancer: A Prospective Multicenter Study

Hitoshi Zembutsu, Seigo Nakamura, Sadako Akashi-Tanaka, Takashi Kuwayama, Chie Watanabe, Tomoko Takamaru, Hiroyuki Takei, Takashi Ishikawa, Kana Miyahara, Hiroshi Matsumoto, Yoshie Hasegawa, Goro Kutomi, Hiroaki Shima, Fukino Satomi, Minoru Okazaki, Hisamitsu Zaha, Mai Onomura, Ayami Matsukata, Yasuaki Sagara, Shinichi Baba, Akimitsu Yamada, Kazuhiro Shimada, Daisuke Shimizu, Koichiro Tsugawa, Arata Shimo, Ern Yu Tan, Mikael Hartman, Ching-Wan Chan, Soo Chin Lee, Yusuke Nakamura
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (8): 2019–2026.
https://doi.org/10.1158/1078-0432.CCR-16-1779
Published: 13 April 2017
View article titled, Significant Effect of Polymorphisms in <em>CYP2D6</em> on Response to Tamoxifen Therapy for Breast Cancer: A Prospective Multicenter Study
Open the PDF for Significant Effect of Polymorphisms in <em>CYP2D6</em> on Response to Tamoxifen Therapy for Breast Cancer: A Prospective Multicenter Study in another window
Includes: Supplementary data
Journal Articles

Ethnicity and Pharmacogenetics of Anticancer Therapy

Boon Cher Goh, Soo-Chin Lee, Lee How-Sung, Lu Fan
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (22_Supplement): CN01-02.
Published: 15 August 2014
View article titled, Ethnicity and Pharmacogenetics of Anticancer Therapy
Journal Articles

Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer

Wen-Son Hsieh, Ross Soo, Bee-Keow Peh, Thomas Loh, Difeng Dong, Donny Soh, Lim-Soon Wong, Simon Green, Judy Chiao, Chun-Ying Cui, Yoke-Fong Lai, Soo-Chin Lee, Benjamin Mow, Richie Soong, Manuel Salto-Tellez, Boon-Cher Goh
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (4): 1435–1442.
https://doi.org/10.1158/1078-0432.CCR-08-1748
Published: 19 February 2009
View article titled, Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer
Open the PDF for Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer in another window
Journal Articles

Pharmacogenetics in Breast Cancer Therapy

Sing-Huang Tan, Soo-Chin Lee, Boon-Cher Goh, John Wong
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (24): 8027–8041.
https://doi.org/10.1158/1078-0432.CCR-08-0993
Published: 15 December 2008
View article titled, Pharmacogenetics in Breast Cancer Therapy
Open the PDF for Pharmacogenetics in Breast Cancer Therapy in another window
Journal Articles

A Pharmacodynamic Model for the Time Course of Tumor Shrinkage by Gemcitabine + Carboplatin in Non–Small Cell Lung Cancer Patients

Lai-San Tham, Lingzhi Wang, Ross A. Soo, Soo-Chin Lee, How-Sung Lee, Wei-Peng Yong, Boon-Cher Goh, Nicholas H.G. Holford
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (13): 4213–4218.
https://doi.org/10.1158/1078-0432.CCR-07-4754
Published: 01 July 2008
View article titled, A Pharmacodynamic Model for the Time Course of Tumor Shrinkage by Gemcitabine + Carboplatin in Non–Small Cell Lung Cancer Patients
Open the PDF for A Pharmacodynamic Model for the Time Course of Tumor Shrinkage by Gemcitabine + Carboplatin in Non–Small Cell Lung Cancer Patients in another window
Journal Articles

Lack of Association of Single-Nucleotide Polymorphisms in Pregnane X Receptor, Hepatic Nuclear Factor 4α, and Constitutive Androstane Receptor with Docetaxel Pharmacokinetics

Lai-San Tham, Nicholas H.G. Holford, Sok-Ying Hor, Theresa Tan, Lingzhi Wang, Rui-Chen Lim, How-Sung Lee, Soo-Chin Lee, Boon-Cher Goh
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (23): 7126–7132.
https://doi.org/10.1158/1078-0432.CCR-07-1276
Published: 03 December 2007
View article titled, Lack of Association of Single-Nucleotide Polymorphisms in <em>Pregnane X Receptor, Hepatic Nuclear Factor 4α</em>, and <em>Constitutive Androstane Receptor</em> with Docetaxel Pharmacokinetics
Open the PDF for Lack of Association of Single-Nucleotide Polymorphisms in <em>Pregnane X Receptor, Hepatic Nuclear Factor 4α</em>, and <em>Constitutive Androstane Receptor</em> with Docetaxel Pharmacokinetics in another window